Replimune Group, Inc – a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies – ...

Savara faces an FDA setback for Molbreevi, its aPAP treatment. Learn how the company plans to recover and file a new BLA by ...

FDA issued Complete Response Letter Capricor plans to resubmit its BLA to include data from the ongoing Phase 3 HOPE-3 trial ...

Replimune Group, Inc. faces FDA setbacks with RP1, raising financial risks and dilution concerns. Click here to find out why ...

The Baloch Liberation Army has claimed responsibility for a bomb blast in Quetta that killed Major Anwar Kakar, a senior ...

Replimune faces FDA hurdles for RP1, an innovative melanoma treatment, as it seeks a path forward after receiving a complete ...

Amid the dusty plateaus and strategic choke points of Balochistan, a covert conflict is rapidly intensifying — one that ...

The Baloch Army (BLA) has claimed responsibility for an attack on a bus carrying Pakistan Army personnel in the Quetta and ...

Fateh Squad of Baloch Liberation Army ambushed a military bus going from Karachi to Quetta killing at least 29 military ...

The FDA's request stems from observations made during recent inspections of Ultragenyx's manufacturing facilities.

Nanoscope’s BLA has been granted rolling review by the FDA, with the first modules already submitted. The completion of the ...